Please login to the form below
treatment
This page shows the latest treatment news and features for those working in and with pharma, biotech and healthcare.
Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
The potential of AstraZeneca (AZ) and Daichii Sankyo’s targeted treatment for advanced breast cancer, Enhertu (trastuzumab deruxtecan), has been recognised by the National Institute for Health and Care Excellence (NICE), ... despite not being
Latest news
-
ScreenPoint Medical to showcase AI software at European scientific meeting
2023. The software aims to improve breast cancer survival rates by detecting cancer earlier and making treatment more effective and less intense.
-
Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
The companies will work together to develop new cardiovascular treatments. Novo Nordisk has announced that it has entered into a partnership with Valo Health, worth up to $60m, to discover and ... develop new treatments for cardiometabolic diseases.
-
Sandoz biosimilar receives EC approval to treat MS
Tyruko is the first and only biosimilar treatment for relapsing-remitting MS in Europe. ... Today’s approval brings us one step closer to reducing the burden of this disease for those living with multiple sclerosis in Europe by making the
-
Novo Nordisk Foundation commits €127m for new cell therapy facility
The new facility will help accelerate treatments for people living with chronic diseases. ... This will help to accelerate treatments for people with diseases including chronic heart failure, Parkinson’s disease, kidney disease, type 1 diabetes and
-
ICR and Merck renew strategic alliance for development of new cancer drugs
small-molecule therapeutics”, which could lead to “delivering new, life-saving treatments to cancer patients”.
More from news
Approximately 35 fully matching, plus 5,609 partially matching documents found.
Latest Intelligence
-
Diversity and inclusion in clinical trials: keeping up momentum
FDA commissioner Robert M Califf commented: “Going forward, achieving greater diversity will be a key focus throughout the FDA to facilitate the development of better treatments and better ways to fight ... Medicines work differently in different people
-
How to create value in your business
High-quality solutions for our clients. And, most importantly, maximising the value of different treatments for patients.
-
Harnessing innovation to change the future of chronic diseases in Europe
Our efforts have paid off, with multiple blockbuster treatments launched over recent decades that have improved millions of lives worldwide. ... We have great therapies today that can stop and reverse many chronic diseases, but there are also incredible
-
Point.1 – HCP data with purpose and perception
There, our data shows 45% of dermatologists are actively influenced by patient opinions in the ‘aware’ stages of their decision journey when it comes to determining the right treatment for them.
-
The importance of accelerating clinical trial diversity
Clinical trials are the highway to new treatment, but their diversity is stuck in the slow lane. ... The trial should represent the patient population that the treatment aims to benefit,” she observed.
More from intelligence
Approximately 3 fully matching, plus 864 partially matching documents found.
Latest appointments
-
Lilly announces two new senior leadership hires
Batterham is recognised as a clinical leader in the field of obesity through her research identifying the role of gut hormones as treatments for obesity. ... Rachel and Emily’s extensive experience will be invaluable as we work to deliver innovative
-
Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
Commercial and medical organisations will need to hyper personalise their conversations with their customers, to explain complex treatment pathways, modes of action and patient challenges.
-
Claire Gillis appointed to newly created role of CEO of VMLY&R HEALTH
Gillis joined VMLY&R in 2020 to launch a specialist international agency, focusing on prescription pharma companies developing breakthrough treatments.
-
Mark Caulfield departs from Genomics England to take on CEO role at Barts Life Sciences
First launched in 2012, the 100, 000 Genome Project had ambitious plans to map the genomes of NHS patients to deliver treatments for those with rare inherited diseases and cancer.
-
AZ appoints Susan Galbraith as executive vice president, oncology R&D
This includes PARP inhibitor Lynparza (olaparib), third-generation tyrosine kinase inhibitor (TKI) Tagrisso (osimertinib), the recently approved MET inhibitor Orpathys (savolitinib) and Koselugo (selumetinib) – indicated for the treatment of
More from appointments
Approximately 0 fully matching, plus 228 partially matching documents found.
Latest from PMHub
-
emotive supports Rare Disease Day 2019
with promoting earlier diagnosis and access to novel treatments.
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
Children can be left facing an uncertain future and an unclear treatment pathway when they have a rare disorder. ... Numerous unknown disorders have been identified with clarity, finally providing diagnosis and treatment options to thousands.
-
Modernising the Mental Health Act: Published Today
Giving patients a voice when considering their treatment options is something we care about deeply. ... Understanding and cooperative treatment plans will improve the efficacy of administration to those with mental health difficulties.
-
Breaking the silence: It’s time to talk about the menopause
open up the conversation, encouraging women to demand better access to care and treatment, rather than suffer in silence. ... Furthermore, 69% agreed there should be more treatments available for the symptoms of menopause.
-
After a busy first quarter, emotive welcomes five new team members
treatment of rare diseases.” said Dorothy at the end of her second day with us.
More from PMHub
Approximately 31 fully matching, plus 706 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Medscape Education Global
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
